Skip to Content


In the US, Romiplostim (romiplostim systemic) is a member of the drug class platelet-stimulating agents and is used to treat Idiopathic Thrombocytopenic Purpura.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Hematopoietic growth factor: Stimulation of thrombopoiesis

Hemostatic agent: Treatment of thrombocytopenia

Thrombopoietin receptor agonist

Chemical Names

L-metionyl [human immunglobulin heavy constant gamma 1-(227 C-terminal residues)-peptide (Fc fragment)] fusion protein wit 41 amino acids peptide, (7-7':10,10')-bisdisulfide dimer (WHO)

Metionyl, 227 amino acid C-terminal Immunoglobulin G1 (human Fc fragment) fusion protein wit 41 amino acid peptide, dimer (USAN)

Foreign Names

  • Romiplostimum (Latin)
  • Romiplostim (German)
  • Romiplostim (French)
  • Romiplostim (Spanish)

Generic Names

Brand Names

  • Nplate
    Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Hungary; Amgen, Iceland; Amgen, Lithuania; Amgen, Norway; Amgen, Portugal; Amgen, Romania; Amgen, Sweden; Amgen, Slovakia; Amgen, United States; Amgen Austria, Austria; Amgen Dompè, Italy; Amgen Europe, Denmark; Amgen Europe, Netherlands; Amgen Europe, Poland; Amgen Europe, Slovenia; Amgen Ltd., Ireland; Amgen Mexico, Mexico; Amgen Switzerland, Switzerland; Amgen Technology, Israel; Batswadi, South Africa; Kyowa Kirin, Hong Kong
  • Romiplate
    Kyowa Hakko Kirin, Japan


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.